Abstract

ObjectiveTo investigate the impact of postoperative infectious complications (POI) on the long-term outcomes of patients with colorectal cancer liver metastasis (CRLM) after simultaneous resection of colorectal cancer and liver metastases.MethodsFour hundred seventy-nine CRLM patients receiving simultaneous resection between February 2010 and February 2018 at our hospital were enrolled. A 1:3 propensity score matching analysis (PSM) analysis was performed to balance covariates and avoid selection bias. After PSM, 90 patients were distributed to the POI group, and 233 patients were distributed to the no POI group. A log-rank test was performed to compare the progression-free survival (PFS) and overall survival (OS) data. A multivariate Cox regression model was employed to identify prognostic factors influencing OS and PFS. A value of two-sided P<0.05 was considered statistically significant.ResultsCompared to patients in the no POI group, patients in the POI group were more likely to have hepatic portal occlusion (78.9% vs. 66.3%, P=0.021), operation time ≥325 min (61.1% vs. 48.1%, P=0.026), and intraoperative blood loss ≥200 ml (81.1% vs. 67.6%, P=0.012). In multivariate analysis, intraoperative blood loss ≥200 ml (OR = 2.057, 95% CI: 1.165-3.634, P=0.013) was identified as the only independent risk factor for POI. Patients with POI had a worse PFS (P<0.001, median PFS: 7.5 vs. 12.7 months) and a worse OS (P=0.010, median OS: 38.8 vs. 59.0 months) than those without POI. After 1:3 PSM analysis, no differences in clinicopathologic parameters were detected between the POI group and the no POI group. Patients with POI had a worse PFS (P=0.013, median PFS: 7.5 vs. 11.1 months) and a worse OS (P=0.020, median OS: 38.8 vs. 59.0 months) than those without POI. Multivariate analysis showed that POI was an independent predictor for worse PFS (HR=1.410, 95% CI: 1.065-1.869, P=0.017) and worse OS (HR=1.682, 95% CI: 1.113-2.544, P=0.014).ConclusionsPOI can significantly worsen the long-term outcomes of CRLM patients receiving simultaneous resection of colorectal cancer and liver metastases and should be considered to improve postoperative management and make better treatment decisions for these patients.

Highlights

  • Colorectal cancer (CRC) is the third most common malignant cancer and the second leading cause of cancer-related death in the world [1]

  • Multivariate analysis showed that Postoperative infectious complications (POI) was an independent predictor of both worse progression-free survival (PFS) (HR=1.410, 95% confidence intervals (CIs): 1.065-1.869, P=0.017) (Table 6) and worse overall survival (OS) (HR=1.682, 95% CI: 1.1132.544, P=0.014) (Table 7)

  • A study suggested that infection caused by E. coli [26] could contribute to the formation of a protumorigenic environment in the liver and recruit circulating tumor cells, promoting liver metastases of colorectal cancer

Read more

Summary

Introduction

Colorectal cancer (CRC) is the third most common malignant cancer and the second leading cause of cancer-related death in the world [1]. The liver is the most common metastatic site, and more than 50% [2] of patients with colorectal cancer will develop liver metastases during their lifetimes. Liver metastases are often the cause of death for these colorectal cancer liver metastasis (CRLM) patients. With the development of surgical technology, the improvement of the safety of hepatectomy [4] and the successful preoperative systematic treatment [5], simultaneous resection of the primary tumor and liver metastases in one operation has been increasing [6]. Several retrospective studies [7,8,9] revealed that patients receiving simultaneous resection could have comparable long-term outcomes to those receiving staged resection. A recent randomized controlled trial [10] revealed that long-term outcomes tended to be improved in the simultaneous resection group compared with the staged resection group

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call